aTyr Pharma, Inc. Common Stock

ATYR XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

51M

Short interest (May 15)

21.8%

Net Short (Jun 03 ): -0.1%

Borrow Fee

1.21%

↓ 8.3%

Available Shares

700K

↑ 16.2%

Price Chart

Company Overview

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001339970

Asset Type: CS

Market Data

Market Cap: $50,986,630

Employees: 58

Status: Active

Short Interest

Current Borrow Fee 1.21%

Range: 1.17% - 1.23%

Available Shares 700K

Range: 500K - 750K

Recent Changes

Fee Change: ↓ 1.9%

Available Change: ↑ 225.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime